Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Girard

Showing results (201-210 of 396) with videos related to

Pageof 40
Sort By:
Clinical Lung Cancer|December 12, 2022
Prospective Radiologic-Pathologic Correlation of Macroscopic Volume and Microscopic Extension of Nonsolid Lung Nodules on Thin-section CT Images for Sublobar Resection and Stereotactic Radiotherapy PlanningArnaud Beddok, Marie-Laure Chabi-Charvillat, Titouan Kennel, et al.
ESMO Open|December 2, 2020
First results of the EORTC-SPECTA/Arcagen study exploring the genomics of rare cancers in collaboration with the European reference network EURACANMarie Morfouace, Aleksandra Stevovic, Marie Vinches, et al.
International Journal of Cancer|June 8, 2026
High-Throughput Geocoding to Assess Short-Term Air Pollution in Correlation With Mortality in a French Cancer Patient CohortLoice Pokam, Joséphine Bocquet, Nadia Hégarat, et al.
International Journal of Radiation Oncology, Biology, Physics|June 24, 2006
Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trialFrançoise Mornex, Nicolas Girard, Jean-Yves Scoazec, et al.
Clinical Therapeutics|November 2, 2025
Real-World Characteristics, Treatment Patterns, and Outcomes in Advanced HER2 (ERBB2)-Mutant Non-Small Cell Lung Cancer: A Retrospective Study of Single Centers in France and GermanyPetros Christopoulos, Christin Assmann, Lirong Zhang, et al.
Clinical Lung Cancer|February 27, 2026
TIGOS Trial: A Randomized, Double-Blind, Phase III Trial of Atigotatug and Nivolumab Fixed-Dose Combination With Chemotherapy Versus Atezolizumab With Chemotherapy as First-Line Therapy in Patients With Extensive-Stage Small Cell Lung CancerLuis G Paz-Ares, Kenneth John O'Byrne, Melissa L Johnson, et al.
Lung Cancer (Amsterdam, Netherlands)|February 22, 2025
Comparative effectiveness and safety of tislelizumab versus other anti-PD-(L)1 agents in first- and subsequent lines in locally advanced or metastatic non-small cell lung cancer: Systematic literature review and network meta-analysisNicolas Girard, Ji-Youn Han, Ross A Soo, et al.
Annals of Nuclear Medicine|October 18, 2020
FDG-PET biomarkers associated with long-term benefit from first-line immunotherapy in patients with advanced non-small cell lung cancerRomain-David Seban, Jean-Baptiste Assie, Etienne Giroux-Leprieur, et al.
Bone|January 17, 2018
Bone, muscle, and metabolic parameters predict survival in patients with synchronous bone metastases from lung cancersLauriane Chambard, Nicolas Girard, Edouard Ollier, et al.
Oncotarget|April 19, 2017
MET exon 14 mutations as targets in routine molecular analysis of primary sarcomatoid carcinoma of the lungRaphaël Saffroy, Vincent Fallet, Nicolas Girard, et al.
Pageof 40

Showing results (201-210 of 396) with videos related to

Sort By:
Pageof 40
Clinical Lung Cancer|December 12, 2022
Prospective Radiologic-Pathologic Correlation of Macroscopic Volume and Microscopic Extension of Nonsolid Lung Nodules on Thin-section CT Images for Sublobar Resection and Stereotactic Radiotherapy PlanningArnaud Beddok, Marie-Laure Chabi-Charvillat, Titouan Kennel, et al.
ESMO Open|December 2, 2020
First results of the EORTC-SPECTA/Arcagen study exploring the genomics of rare cancers in collaboration with the European reference network EURACANMarie Morfouace, Aleksandra Stevovic, Marie Vinches, et al.
International Journal of Cancer|June 8, 2026
High-Throughput Geocoding to Assess Short-Term Air Pollution in Correlation With Mortality in a French Cancer Patient CohortLoice Pokam, Joséphine Bocquet, Nadia Hégarat, et al.
International Journal of Radiation Oncology, Biology, Physics|June 24, 2006
Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trialFrançoise Mornex, Nicolas Girard, Jean-Yves Scoazec, et al.
Clinical Therapeutics|November 2, 2025
Real-World Characteristics, Treatment Patterns, and Outcomes in Advanced HER2 (ERBB2)-Mutant Non-Small Cell Lung Cancer: A Retrospective Study of Single Centers in France and GermanyPetros Christopoulos, Christin Assmann, Lirong Zhang, et al.
Clinical Lung Cancer|February 27, 2026
TIGOS Trial: A Randomized, Double-Blind, Phase III Trial of Atigotatug and Nivolumab Fixed-Dose Combination With Chemotherapy Versus Atezolizumab With Chemotherapy as First-Line Therapy in Patients With Extensive-Stage Small Cell Lung CancerLuis G Paz-Ares, Kenneth John O'Byrne, Melissa L Johnson, et al.
Lung Cancer (Amsterdam, Netherlands)|February 22, 2025
Comparative effectiveness and safety of tislelizumab versus other anti-PD-(L)1 agents in first- and subsequent lines in locally advanced or metastatic non-small cell lung cancer: Systematic literature review and network meta-analysisNicolas Girard, Ji-Youn Han, Ross A Soo, et al.
Annals of Nuclear Medicine|October 18, 2020
FDG-PET biomarkers associated with long-term benefit from first-line immunotherapy in patients with advanced non-small cell lung cancerRomain-David Seban, Jean-Baptiste Assie, Etienne Giroux-Leprieur, et al.
Bone|January 17, 2018
Bone, muscle, and metabolic parameters predict survival in patients with synchronous bone metastases from lung cancersLauriane Chambard, Nicolas Girard, Edouard Ollier, et al.
Oncotarget|April 19, 2017
MET exon 14 mutations as targets in routine molecular analysis of primary sarcomatoid carcinoma of the lungRaphaël Saffroy, Vincent Fallet, Nicolas Girard, et al.
Pageof 40